Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases

Clinical trial NCT06278454 · RECRUITING

Trial details

NCT number: NCT06278454
Sponsor: Chengdu New Radiomedicine Technology Co. LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Unresectable Pancreatic Cancer Advanced Pancreatic Cancer Lymph Node Metastases

Start date: 2024-01-09
Primary completion: 2027-12-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.